Overview / Abstract: |
This discussion with Program Chair Christina Y. Weng, MD, MBA, and David A Eichenbaum, MD, includes a case study that highlights challenges with managing diabetic eye disease during the COVID era and how longer duration therapies could be beneficial. Drs. Weng and Eichenbaum also converse about the latest data on pipeline therapies for diabetic macular edema, including faricimab, KSI-301, and OPT-302. |
Expiration |
Nov 30, 2022 |
Discipline(s) |
Optometry / Ophthalmology CE |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
0.5 |
Accreditation |
ACCME |
Keywords / Search Terms |
Evolve Medical Education LLC Free CE CME |